Even with access to blockbuster obesity drugs, some people don't lose weight
In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...
The i on MSN14h
‘I got a Wegovy weight-loss pen online – it’s shocking how easy it is’
Shirleyann Metcalfe, 64, told i she was almost instantly approved for online pharmacist Voy’s GLP1 weight-loss programme – ...
News94h
Medical Minute: Weight Loss Drugs Effective But Carry Risks, Experts Warn
Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...
Are Hedge Funds Betting Big on Novo Nordisk (NVO)’s Diabetes and Chronic Disease Care?
We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...
Ozempic’s maker wants the US government to ban cheaper versions of the high-priced $969 injection weight-loss drug – claims the formula is ‘too complex’ to cop…
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
pharmaphorum21h
Sought-after obesity drug Wegovy backed for NHS use
Novo Nordisk’s weekly injectable drug Wegovy, which can help people lose more than 10% of their body weight, has been cleared for use on the NHS in England by cost-effectiveness agency NICE.